Your browser doesn't support javascript.
loading
Outcomes of Patients With Takotsubo Syndrome Compared With Type 1 and Type 2 Myocardial Infarction.
Khaloo, Pegah; Ledesma, Pablo A; Nahlawi, Acile; Galvin, Jennifer; Ptaszek, Leon M; Ruskin, Jeremy N.
Afiliación
  • Khaloo P; Cardiac Arrhythmia Service, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Ledesma PA; Cardiac Arrhythmia Service, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Nahlawi A; Cardiac Arrhythmia Service, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Galvin J; Cardiac Arrhythmia Service, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Ptaszek LM; Cardiac Arrhythmia Service, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Ruskin JN; Cardiac Arrhythmia Service, Massachusetts General Hospital Harvard Medical School Boston MA.
J Am Heart Assoc ; 12(18): e030114, 2023 09 19.
Article en En | MEDLINE | ID: mdl-37681546
Background Takotsubo syndrome (TS) and myocardial infarction (MI) share similar clinical and laboratory characteristics but have important differences in causes, demographics, management, and outcomes. Methods and Results In this observational study, the National Inpatient Sample and National Readmission Database were used to identify patients admitted with TS, type 1 MI, or type 2 MI in the United States between October 1, 2017, and December 31, 2019. We compared patients hospitalized with TS, type 1 MI, and type 2 MI with respect to key features and outcomes. Over the 27-month study period, 2 035 055 patients with type 1 MI, 639 075 patients with type 2 MI, and 43 335 patients with TS were identified. Cardiac arrest, ventricular fibrillation, and ventricular tachycardia were more prevalent in type 1 MI (4.02%, 3.2%, and 7.2%, respectively) compared with both type 2 MI (2.8%, 0.8%, and 5.4% respectively) and TS (2.7%, 1.8%, and 5.3%, respectively). Risk of mortality was lower in TS compared with both type 1 MI (3.3% versus 7.9%; adjusted odds ratio [OR], 0.3; P<0.001) and type 2 MI (3.3% versus 8.2%; adjusted OR, 0.3; P<0.001). Mortality rate (OR, 1.2; P<0.001) and cardiac-cause 30-day readmission rate (adjusted OR, 1.7; P<0.001) were higher in type 1 MI than in type 2 MI. Conclusions Patients with type 1 MI had the highest rates of in-hospital mortality and cardiac-cause 30-day readmission. Risk of all-cause 30-day readmission was highest in patients with type 2 MI. The risk of ventricular arrhythmias in patients with TS is lower than in patients with type 1 MI but higher than in patients with type 2 MI.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía de Takotsubo / Infarto de la Pared Anterior del Miocardio / Infarto del Miocardio Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Am Heart Assoc Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía de Takotsubo / Infarto de la Pared Anterior del Miocardio / Infarto del Miocardio Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Am Heart Assoc Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido